| Product NDC: | 63323-355 |
| Proprietary Name: | Levofloxacin |
| Non Proprietary Name: | LEVOFLOXACIN |
| Active Ingredient(s): | 5 mg/mL & nbsp; LEVOFLOXACIN |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 63323-355 |
| Labeler Name: | Fresenius Kabi USA, LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA200674 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20130620 |
| Package NDC: | 63323-355-65 |
| Package Description: | 1 BAG in 1 POUCH (63323-355-65) > 100 mL in 1 BAG |
| NDC Code | 63323-355-65 |
| Proprietary Name | Levofloxacin |
| Package Description | 1 BAG in 1 POUCH (63323-355-65) > 100 mL in 1 BAG |
| Product NDC | 63323-355 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | LEVOFLOXACIN |
| Dosage Form Name | INJECTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20130620 |
| Marketing Category Name | ANDA |
| Labeler Name | Fresenius Kabi USA, LLC |
| Substance Name | LEVOFLOXACIN |
| Strength Number | 5 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes |